These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7948843)

  • 1. MK-801 and NBQX prevent electrically induced status epilepticus.
    Young D; Dragunow M
    Neuroreport; 1994 Jul; 5(12):1481-4. PubMed ID: 7948843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-NMDA glutamate receptors are involved in the maintenance of status epilepticus.
    Young D; Dragunow M
    Neuroreport; 1993 Oct; 5(1):81-3. PubMed ID: 8280865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low doses of NMDA receptor antagonists synergistically increase the anticonvulsant effect of the AMPA receptor antagonist NBQX in the kindling model of epilepsy.
    Löscher W; Rundfeldt C; Hönack D
    Eur J Neurosci; 1993 Nov; 5(11):1545-50. PubMed ID: 7904524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postischemic blockade of AMPA but not NMDA receptors mitigates neuronal damage in the rat brain following transient severe cerebral ischemia.
    Nellgård B; Wieloch T
    J Cereb Blood Flow Metab; 1992 Jan; 12(1):2-11. PubMed ID: 1345757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kainic acid-induced seizures and brain damage in the rat: different effects of NMDA- and AMPA receptor antagonists.
    Berg M; Bruhn T; Johansen FF; Diemer NH
    Pharmacol Toxicol; 1993 Nov; 73(5):262-8. PubMed ID: 8115308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of three NMDA receptor antagonists in the treatment of prolonged status epilepticus.
    Yen W; Williamson J; Bertram EH; Kapur J
    Epilepsy Res; 2004 Mar; 59(1):43-50. PubMed ID: 15135166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-NMDA receptor antagonist-induced drinking in rat.
    Xu Z; Johnson AK
    Brain Res; 1998 Oct; 808(1):124-7. PubMed ID: 9795183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NMDA-receptor blockers but not NBQX, an AMPA-receptor antagonist, inhibit spreading depression in the rat brain.
    Nellgård B; Wieloch T
    Acta Physiol Scand; 1992 Dec; 146(4):497-503. PubMed ID: 1283483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lowered brain stimulation reward thresholds in rats treated with a combination of caffeine and N-methyl-D-aspartate but not alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate or metabotropic glutamate receptor-5 receptor antagonists.
    Bespalov A; Dravolina O; Belozertseva I; Adamcio B; Zvartau E
    Behav Pharmacol; 2006 Jun; 17(4):295-302. PubMed ID: 16914947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuronal damage induced by beta-N-oxalylamino-L-alanine, in the rat hippocampus, can be prevented by a non-NMDA antagonist, 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline.
    Willis CL; Meldrum BS; Nunn PB; Anderton BH; Leigh PN
    Brain Res; 1993 Nov; 627(1):55-62. PubMed ID: 7507397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The metabotropic glutamate receptor agonist 1S,3R-ACPD stimulates and modulates NMDA receptor mediated excitotoxicity in organotypic hippocampal slice cultures.
    Blaabjerg M; Kristensen BW; Bonde C; Zimmer J
    Brain Res; 2001 Apr; 898(1):91-104. PubMed ID: 11292452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AMPA, but not NMDA, receptor antagonism is neuroprotective in gerbil global ischaemia, even when delayed 24 h.
    Sheardown MJ; Suzdak PD; Nordholm L
    Eur J Pharmacol; 1993 Jun; 236(3):347-53. PubMed ID: 7689464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiation of MK-801-induced breathing impairment by 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline.
    McManigle JE; Taveira DaSilva AM; Dretchen KL; Gillis RA
    Eur J Pharmacol; 1994 Jan; 252(1):11-7. PubMed ID: 8149990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LU 73068, a new non-NMDA and glycine/NMDA receptor antagonist: pharmacological characterization and comparison with NBQX and L-701,324 in the kindling model of epilepsy.
    Potschka H; Löscher W; Wlaź P; Behl B; Hofmann HP; Treiber HJ; Szabo L
    Br J Pharmacol; 1998 Nov; 125(6):1258-66. PubMed ID: 9863655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The glutamatergic N-methyl-D-aspartate and non-N-methyl-D-aspartate receptors in the joint contribute to the induction, but not maintenance, of arthritic pain in rats.
    Zhang GH; Yoon YW; Lee KS; Min SS; Hong SK; Park JY; Han HC
    Neurosci Lett; 2003 Nov; 351(3):177-80. PubMed ID: 14623135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estradiol regulates hippocampal dendritic spine density via an N-methyl-D-aspartate receptor-dependent mechanism.
    Woolley CS; McEwen BS
    J Neurosci; 1994 Dec; 14(12):7680-7. PubMed ID: 7996203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous blockade of non-NMDA ionotropic receptors and NMDA receptor-associated ionophore partially protects hippocampal slices from protein synthesis impairment due to simulated ischemia.
    Virgili M; Contestabile A; Barnabei O
    Hippocampus; 1995; 5(1):91-7. PubMed ID: 7787950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analgesic effects of ionotropic glutamate receptor antagonists MK-801 and NBQX on collagen-induced arthritis rats].
    Zhu H; Zhu R; Deng ZD; Feng YC; Shen HL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):977-981. PubMed ID: 27987500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropeptide Y release from cultured hippocampal neurons: stimulation by glutamate acting at N-methyl-D-aspartate and AMPA receptors.
    Gemignani A; Marchese S; Fontana G; Raiteri M
    Neuroscience; 1997 Nov; 81(1):23-31. PubMed ID: 9300398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Group II metabotropic and alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)/kainate glutamate receptors regulate the deficit in brain reward function associated with nicotine withdrawal in rats.
    Kenny PJ; Gasparini F; Markou A
    J Pharmacol Exp Ther; 2003 Sep; 306(3):1068-76. PubMed ID: 12805481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.